Compounds > pixantrone
Page last updated: 2024-09-04

pixantrone and Multiple Sclerosis

pixantrone has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonsette, RE1
Dubois, B; Gonsette, RE1

Reviews

2 review(s) available for pixantrone and Multiple Sclerosis

ArticleYear
A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:4

    Topics: Adjuvants, Immunologic; Antioxidants; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Immunosuppressive Agents; Isoquinolines; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents

2004
Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity.
    Journal of the neurological sciences, 2004, Aug-15, Volume: 223, Issue:1

    Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Heart; Humans; Immunosuppressive Agents; Immunotherapy; Isoquinolines; Mitoxantrone; Multiple Sclerosis

2004